A Two Arm, Randomized, Open Labeled, Prospective, Clinical Study to Evaluate efficacy and safety of Dabur Chyawanprash in Health & Immunity related Parameters in Healthy children â?? A School Based Study

Dabur India Limited0 个研究点目标入组 702 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1 Healthy children of either sex of 5-12 years (both inclusive)
•2 Ready to provide informed consent from parent/ legally accepted guardian
•3 No significant medical or surgical disease/s at the time of screening
•4 No history of allergic conditions to Chyawanprash like products/any ingredients of the Chyawanprash and are not averse to consuming Chyawanprash for the study period
•5 Willing to come for the follow up visits for evaluation

•1 Presence of any clinically significant medical or surgical condition requiring long term treatment
•2 Subjects participating/participated in another clinical study within 3 months before recruitment
•3 Evidence of significant uncontrolled concomitant disease which in the Investigators opinion would preclude patient participation
•4 Immunologically compromised children

发起方